Radiation response and combination target discovery in a novel model of rectal cancer
<p>Rectal cancer is typically treated with radiotherapy, with or without chemotherapy, prior to surgical resection of the tumour. However, in patients that respond poorly to radiation, tumours largely lack significant immune cells within the surrounding milieu and present with a CAF-rich strom...
Huvudupphovsman: | Beach, CJ |
---|---|
Övriga upphovsmän: | Leedham, S |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
2024
|
Ämnen: |
Liknande verk
Liknande verk
-
Evaluation of Quality of Life, Depression and Anxiety in Patients with Rectal Cancer Receiving Radiotherapy
av: Feryal Karaca, et al.
Publicerad: (2020-02-01) -
On the trail of CBCT-guided adaptive rectal boost radiotherapy, does daily delineation require a radiation oncologist?
av: Julien Pierrard, et al.
Publicerad: (2024-12-01) -
Efficacy of radiotherapy in patients with rectal cancer undergoing chemotherapy and surgery: a retrospective study based on the SEER database
av: WANG Anjun, et al.
Publicerad: (2023-03-01) -
Assessment of Variations in Serum Testosterone, Follicle Stimulating Hormone, and Luteinizing Hormone Levels in Patients Receiving Radiotherapy for Rectal Cancer
av: Abhishek Krishna, et al.
Publicerad: (2022-04-01) -
Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
av: Catherine R. Hanna, et al.
Publicerad: (2021-05-01)